John David Hansen is CEO & President at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX). They have made 6 open-market trades across 1 company since 2016, most recently 2018-04-02.
CIK 0001186123
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2016, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MBVX | 195,516 | $225K |
Shares reported on the most recent Form 4, priced at the 2018-04-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBVX | SELL | 2018-01-16 | 2018-01-18 | $0.92 | $109K | -16.2% | -6.6% | -42.6% |
| MBVX | SELL | 2018-01-10 | 2018-01-16 | $0.97 | $355K | -14.5% | -25.5% | -46.8% |
| MBVX | BUY | 2017-05-19 | 2017-08-02 | $1.75 | $8K | -21.4% | -37.1% | -11.4% |
| MBVX | SELL | 2017-04-12 | 2017-04-14 | $2.00 | $20K | +7.2% | +3.0% | -49.7% |
| MBVX | SELL | 2017-04-07 | 2017-04-11 | $2.00 | $3K | +5.8% | -1.1% | -45.8% |
| MBVX | SELL | 2017-04-04 | 2017-04-06 | $2.17 | $11K | -6.9% | -4.9% | -37.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.